MedMira Gets CE Mark for Its Multiplo Syphilis Antibody Test

MedMira has received a CE mark for its Multiplo Complete Syphilis antibody test, which targets biomarkers that indicate active as well as previous infections.

The combined screening and confirmation test, which is for use in hospitals, takes less than three minutes from sample collection to results.

Based on the company’s rapid vertical flow (RVF) technology, the test detects antibodies of treponemal (TP) bacteria associated with syphilis as well as nontreponemal (nTP) antibodies that indicate active or recent infection.

In March, the Halifax, Nova Scotia-based company received a CE mark for its Reveal TP (syphilis) antibody test, intended to diagnose acute syphilis infections.